Director Carrico Brian Allen 🟡 adjusted position in 120.8K shares (3 derivative) of Neuraxis, INC (NRXS) Transaction Date: Aug 24, 2026 | Filing ID: 040274
Currault Douglas N. II 🟡 adjusted position in 80.0K shares (2 derivative) of FREEPORT-MCMORAN INC (FCX) at $78.56 ($8.7M) Transaction Date: Aug 25, 2026 | Filing ID: 010926
📋 Atlas Venture Opportunity Fund II, L.P. (Shareholder) plans to sell 51 shares of Korro Bio, Inc. (at $13.73 each, total $700.23) Filed: Aug 26, 2026 | ID: 059121